American Healthcare REIT, Inc.
AHR
Peringkat dalam Saham
#1812
American Healthcare REIT (AHR) was forged through a significant strategic... American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated management platform, staffed by over one hundred highly experienced and proficient professionals. Many members of this team have a long history of collaboration, dating back to 2006, and have successfully invested in and overseen healthcare real estate assets across diverse market cycles. Their collective expertise, extensive industry network, and deep, firsthand understanding of each property within the international portfolio – which they have meticulously built and managed since its first acquisition in 2014 – are unparalleled. This powerful combination of a robust management team and a high-quality asset base strategically positions American Healthcare REIT to capitalize on compelling growth opportunities, driven by significant demographic trends. Its expansive portfolio encompasses 19 million square feet across 312 distinct properties, including medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. This diverse collection is strategically distributed across 36 U.S. states and the United Kingdom. The aforementioned tri-party transaction represented a pivotal step in ideally preparing American Healthcare REIT for a future public listing or Initial Public Offering (IPO) on a national stock exchange when market conditions are most favorable. By eventually listing its shares, the company anticipates gaining enhanced access to attractive capital sources, which will be crucial for fueling future expansion, diversifying its investor base, and providing greater liquidity for its existing stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
Harga Saham
$54.20
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$11.79B
Perubahan (1 hari)
3.19%
Perubahan (1 tahun)
28.76%
Negara
US
Perdagangan American Healthcare REIT, Inc. (AHR)
Kategori
Real Estate
Rasio P/E untuk American Healthcare REIT, Inc. (AHR)
Rasio P/E per October 2026 TTM: 77.01
Menurut laporan keuangan dan harga saham terbaru dari American Healthcare REIT, Inc., rasio P/E saat ini (TTM) adalah 77.01. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar -12.22.
Riwayat rasio P/E untuk American Healthcare REIT, Inc. dari 2016 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 77.01 | -178.43% |
| 2024 | -98.19 | 703.70% |
| 2023 | -12.22 | 13.48% |
| 2022 | -10.77 | -41.21% |
| 2021 | -18.31 | -104.54% |
| 2020 | 403.67 | -433.33% |
| 2019 | -121.10 | -343.68% |
| 2018 | 49.70 | -14.87% |
| 2017 | 58.38 | -1,428.35% |
| 2016 | -4.40 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 120.30 | 56.21% |
US
|
|
| 153.29 | 99.06% |
US
|
|
| 15.60 | -79.74% |
US
|
|
| 53.54 | -30.47% |
US
|
|
| - | - |
US
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.